Immunoclin Corp Debt Conversion, Converted Instrument, Amount
Immunoclin Corp reported Debt Conversion, Converted Instrument, Amount of $86.51 thousand for the 12-month period ending 2014-01-31, per its 10-Q filed 2014-07-24.
Discontinued › Cash Flow › Financing Activities
us-gaap:DebtConversionConvertedInstrumentAmount1 · last filed 2014-07-24
- Immunoclin Corp debt conversion, converted instrument, amount for fiscal 2013 was $36.43K.
| Period end | Debt Conversion, Converted Instrument, Amount 9 month | Debt Conversion, Converted Instrument, Amount 12 month | Debt Conversion, Converted Instrument, Amount 34 month |
|---|---|---|---|
| 2014-01-31 | $86.51K 10-Q · filed 2014-07-24 | ||
| 2013-11-30 | $55.15K 10-Q · filed 2014-01-21 | $55.15K 10-Q · filed 2014-01-21 | |
| 2013-01-31 | $36.43K 10-K · filed 2014-07-07 |